UNITED THERAPEUTICS Corp Common Stock Shares Outstanding

• UNITED THERAPEUTICS Corp showed a decrease of -2.7% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from UNITED THERAPEUTICS Corp's annual report (Form 10-K), filed with the SEC on February 25, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2010: 56.39 million shares | Q3 2010: 56.78 million shares | Q1 2011: 57.99 million shares | Q2 2011: 58.31 million shares | Q3 2011: 58.33 million shares | Q1 2012: 53.68 million shares | Q2 2012: 51.70 million shares | Q3 2012: 51.16 million shares | Q1 2013: 50.25 million shares | Q2 2013: 49.84 million shares | Q3 2013: 50.18 million shares | Q1 2014: 49.66 million shares | Q2 2014: 47.23 million shares | Q3 2014: 47.44 million shares | Q1 2015: 46.37 million shares | Q2 2015: 45.69 million shares | Q3 2015: 45.58 million shares | Q1 2016: 44.88 million shares | Q2 2016: 43.73 million shares | Q3 2016: 42.66 million shares | Q1 2017: 45.05 million shares | Q2 2017: 43.44 million shares | Q3 2017: 43.21 million shares | Q1 2018: 43.44 million shares | Q2 2018: 43.56 million shares | Q3 2018: 43.59 million shares | Q1 2019: 43.81 million shares | Q2 2019: 43.85 million shares | Q3 2019: 43.88 million shares | Q1 2020: 44.00 million shares | Q2 2020: 44.36 million shares | Q3 2020: 44.44 million shares | Q1 2021: 44.79 million shares | Q2 2021: 44.89 million shares | Q3 2021: 45.02 million shares | Q1 2022: 45.29 million shares | Q2 2022: 45.49 million shares | Q3 2022: 45.56 million shares | Q1 2023: 46.70 million shares | Q2 2023: 46.91 million shares | Q3 2023: 46.98 million shares | Q1 2024: 44.20 million shares | Q2 2024: 44.42 million shares | Q3 2024: 44.62 million shares | Q1 2025: 45.07 million shares | Q2 2025: 45.22 million shares | Q3 2025: 42.90 million shares.
• Over the full 17 years of available data (2009 to 2025), UNITED THERAPEUTICS Corp's Common Stock Shares Outstanding has declined by 19.5%.
• Historical annual values: Fiscal year 2025: 43.64 million shares | Fiscal year 2024: 44.83 million shares | Fiscal year 2023: 47.04 million shares | Fiscal year 2022: 46.03 million shares | Fiscal year 2021: 45.11 million shares | Fiscal year 2020: 44.51 million shares | Fiscal year 2019: 43.88 million shares | Fiscal year 2018: 43.59 million shares | Fiscal year 2017: 43.24 million shares | Fiscal year 2016: 42.97 million shares | Fiscal year 2015: 45.76 million shares | Fiscal year 2014: 47.11 million shares | Fiscal year 2013: 50.39 million shares | Fiscal year 2012: 50.17 million shares | Fiscal year 2011: 53.61 million shares | Fiscal year 2010: 57.56 million shares | Fiscal year 2009: 54.22 million shares.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026